141 related articles for article (PubMed ID: 15897390)
21. Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.
Ellis L; Pan Y; Smyth GK; George DJ; McCormack C; Williams-Truax R; Mita M; Beck J; Burris H; Ryan G; Atadja P; Butterfoss D; Dugan M; Culver K; Johnstone RW; Prince HM
Clin Cancer Res; 2008 Jul; 14(14):4500-10. PubMed ID: 18628465
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gamma T-cell receptor genes in cutaneous T-cell lymphoma.
Whittaker S; Woolford A; Russell-Jones R; Fraser-Andrews E
Br J Dermatol; 1999 Apr; 140(4):766-7. PubMed ID: 10233347
[No Abstract] [Full Text] [Related]
23. Beyond clonal detection: defining the T-cell clone.
Guitart J
Arch Dermatol; 2005 Sep; 141(9):1159-60. PubMed ID: 16172316
[No Abstract] [Full Text] [Related]
24. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
25. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
26. Is Sézary syndrome a true primary cutaneous lymphoma?
Alaibac M; Pigozzi B; Bordignon M
Int J Dermatol; 2008 Nov; 47(11):1195-6. PubMed ID: 18986460
[No Abstract] [Full Text] [Related]
27. Identification of key regions and genes important in the pathogenesis of sezary syndrome by combining genomic and expression microarrays.
Caprini E; Cristofoletti C; Arcelli D; Fadda P; Citterich MH; Sampogna F; Magrelli A; Censi F; Torreri P; Frontani M; Scala E; Picchio MC; Temperani P; Monopoli A; Lombardo GA; Taruscio D; Narducci MG; Russo G
Cancer Res; 2009 Nov; 69(21):8438-46. PubMed ID: 19843862
[TBL] [Abstract][Full Text] [Related]
28. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.
Kari L; Loboda A; Nebozhyn M; Rook AH; Vonderheid EC; Nichols C; Virok D; Chang C; Horng WH; Johnston J; Wysocka M; Showe MK; Showe LC
J Exp Med; 2003 Jun; 197(11):1477-88. PubMed ID: 12782714
[TBL] [Abstract][Full Text] [Related]
29. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
Kelemen K; Guitart J; Kuzel TM; Goolsby CL; Peterson LC
Am J Clin Pathol; 2008 Jan; 129(1):146-56. PubMed ID: 18089499
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
32. Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL).
Karenko L; Hahtola S; Ranki A
Cytogenet Genome Res; 2007; 118(2-4):353-61. PubMed ID: 18000390
[TBL] [Abstract][Full Text] [Related]
33. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous lymphoma. Foreword.
Johnstone PA
Curr Probl Cancer; 2008; 32(2):42. PubMed ID: 18325432
[No Abstract] [Full Text] [Related]
35. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
[TBL] [Abstract][Full Text] [Related]
36. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
Csomor J; Bognár A; Benedek S; Sinkó J; Fekete S; Krenács L; Matolcsy A; Reiniger L
J Clin Pathol; 2008 Jun; 61(6):770-2. PubMed ID: 18505891
[TBL] [Abstract][Full Text] [Related]
37. A case of erythrodermic-CTCL.
Shimoda T; Aoki M; Takezaki S; Futagami A; Inokuchi K; Sugisaki Y; Kawana S
Leuk Lymphoma; 2006 Aug; 47(8):1708-10. PubMed ID: 16966295
[No Abstract] [Full Text] [Related]
38. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
Whittaker S
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous follicle center lymphoma of the arm with a novel chromosomal translocation t(12;21)(q13;q22): a case report.
Jelic TM; Berry PK; Jubelirer SJ; Plumley L; Hartel PH; Estalilla OC; Chang HH
Am J Hematol; 2006 Jun; 81(6):448-53. PubMed ID: 16680749
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
